Takeda

Need information on Prostap® DCS, CLICK HERE

About Takeda

Takeda UK is the wholly owned UK subsidiary of Japan's largest pharmaceutical company.

Since it was founded more than two centuries ago in Osaka, the Takeda Pharmaceutical Company has grown into a research-based global enterprise employing more than 14,500 people worldwide, with successful affiliates in more than 90 countries throughout Europe, Asia and North America.

Takeda UK was established in 1997 in High Wycombe to spearhead Takeda's expansion into Europe with the launch of Amias ®, which has become the most widely prescribed angiotensin receptor blocker (ARB) in the UK.

Product information

The current Takeda UK portfolio for improving lives comprises two oral diabetes medicines, an angiotensin receptor blocker and a sustained-release formulation for the treatment of prostate cancer, endometriosis and uterine fibroids. To download a patient information leaflet and a summary of product characteristics for each medicine, simply follow the links at the base of this page.

Takeda MDS

Candesartan cilexetil (Amias ®) is prescribed to treat hypertension or heart failure. (2 mg, 4 mg, 8 mg, 16 mg, 32 mg tablets)¹

Pioglitazone HCl (Actos ® ™) is used for the treatment of insufficient glycaemic control in Type 2 diabetes. (15 mg or 30 mg uptitrated to a 45 mg tablet where appropriate)²

Pioglitazone HCl/metformin HCl (Competact ® ™) is prescribed for Type 2 diabetes mellitus, particularly in overweight patients who cannot achieve sufficient glycaemic control at their highest tolerated dose of oral metformin alone. (15 mg/850 mg tablets twice daily)³

References

[1] Amias ® Patient Information Leaflet

[2] Actos ® ™ Patient Information Leaflet

[3] Competact ® ™ Summary of Product Characteristics

Takeda DDS

With effect from 1st July 2009 Wyeth transferred Prostap to Takeda UK.

If you are unable to view PDF documents, please download Adobe Acrobat Reader

Patient Information Leaflets

Actos ® ▼ (Pioglitazone)

Actos ® Patient Information Leaflet Actos ® Summary of Product Characteristics

Amias ® ▼ (Candesartan)

Amias ® Patient Information Leaflet Amias ® Summary of Product Characteristics

Competact ® ▼ (Pioglitazone/Metformin)

Competact ® Patient Information Leaflet Competact ® Summary of Product Characteristics

Prostap ® ▼ (Leuprorelin acetate)

Prostap ® 3 DCS Patient Information Leaflet
Prostap ® 3 DCS Summary of Product Characteristics
Prostap ® SR DCS Patient Information Leaflet
Prostap ® SR DCS Summary of Product Characteristics